Icosavax logo

Icosavax

Seattle, WA

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle.

icosavax.com

Company Details

Founded

2017

Employees

Between 50 - 100 employees

Raised

$235,300,000

Headquarters Location

Seattle, WA

Public

Yes

Acquired

Yes

CEO

Adam K Simpson

Founders

Adam Simpson
Adam Simpson
David Baker
Neil King

Company Collections

These are collections Icosavax is a part of. Click on the collection name to view similar companies.

Icosavax's Tech Stack